Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 5Completed 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1

Interventions

Specimen Handling 41Magnetic Resonance Spectroscopy 27Biopsy 17Gemcitabine 16fludarabine 14Cyclophosphamide 14Carboplatin 14Paclitaxel 12Oxaliplatin 12Cisplatin 12Dexamethasone 11pembrolizumab 9Nivolumab 9Interviews as Topic 9Radiotherapy 8Irinotecan 8Injections 8Fluorouracil 8venetoclax 7Capecitabine 7Bevacizumab 7cemiplimab 6X-Rays 6Rituximab 6Radiosurgery 6Neoadjuvant Therapy 6Drug Therapy 6Doxorubicin 6Calcium Dobesilate 6Blood Specimen Collection 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Peripheral Blood Stem Cell Transplantation × 30 days × Clear all
NCT07582172 2026-05-12

Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

City of Hope Medical Center

Phase 2 Not yet recruiting
35 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡